Aug 09, 2023 / 07:00AM GMT
Operator
Welcome to the Novozymes conference call regarding the interim report for the first half year of 2023. (Operator Instructions) Today, I'm pleased to leave the word to Tobias Cornelius Bjorklund, Head of Investor Relations. Please begin your meeting.
Tobias Cornelius Bjorklund - Novozymes A/S-Head of IR
Thank you, operator, and welcome, everyone, to Novozymes' conference call for the first half of 2023. My name is, as mentioned, Tobias Bjorklund, and I'm the Head of Investor Relations here at Novozymes.
At this call, our CEO, Ester Baiget; and our CFO, Lars Green, will review our performance and key events of the first 6 months of the year as well as the outlook for the full year. Also attending today's call are Tina Fanoe, EVP, Agriculture & Industrial Biosolutions; Amy Byrick, EVP Strategy & Business Transformation; Anders Lund, EVP Consumer Biosolutions; and Claus Fuglsang, CSO and EVP of Research and Development.
The entire call will take about 45 minutes, including time for questions at the end.
Q2 2023 Novozymes A/S Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot